Nature Communications (Feb 2022)

Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes

  • Jakob Woerner,
  • Yidi Huang,
  • Stephan Hutter,
  • Carmelo Gurnari,
  • Jesús María Hernández Sánchez,
  • Janet Wang,
  • Yimin Huang,
  • Daniel Schnabel,
  • Michael Aaby,
  • Wanying Xu,
  • Vedant Thorat,
  • Dongxu Jiang,
  • Babal K. Jha,
  • Mehmet Koyuturk,
  • Jaroslaw P. Maciejewski,
  • Torsten Haferlach,
  • Thomas LaFramboise

DOI
https://doi.org/10.1038/s41467-022-28678-x
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Circulating microbiome has been very little studied for blood malignancies. Here, the authors show specific microbiome signatures in the blood are associated with different types of myeloid malignancies and specific genetic mutations.